Stealth BioTherapeutics Corp. Sponsored ADR Cash Flow from Operating Activities 2019-2022 | MITO
Stealth BioTherapeutics Corp. Sponsored ADR cash flow from operating activities from 2019 to 2022. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Stealth BioTherapeutics Corp. Sponsored ADR Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2021 | $-45 |
| 2020 | $-54 |
| 2019 | $-48 |
| 2018 | $-72 |
| 2017 | $-70 |
